AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Max Drawdown (5Y): 25.65% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 25.65% |
| September 30, 2024 | 25.65% |
| August 31, 2024 | 25.65% |
| July 31, 2024 | 25.65% |
| June 30, 2024 | 25.65% |
| May 31, 2024 | 25.65% |
| April 30, 2024 | 25.65% |
| March 31, 2024 | 25.65% |
| February 29, 2024 | 25.65% |
| January 31, 2024 | 25.65% |
| December 31, 2023 | 25.65% |
| November 30, 2023 | 25.65% |
| October 31, 2023 | 25.65% |
| September 30, 2023 | 25.65% |
| August 31, 2023 | 25.65% |
| July 31, 2023 | 25.65% |
| June 30, 2023 | 25.65% |
| May 31, 2023 | 25.65% |
| April 30, 2023 | 25.65% |
| March 31, 2023 | 25.65% |
| February 28, 2023 | 25.65% |
| January 31, 2023 | 25.65% |
| December 31, 2022 | 25.65% |
| November 30, 2022 | 25.65% |
| October 31, 2022 | 25.65% |
| Date | Value |
|---|---|
| September 30, 2022 | 25.65% |
| August 31, 2022 | 24.28% |
| July 31, 2022 | 24.28% |
| June 30, 2022 | 24.28% |
| May 31, 2022 | 24.28% |
| April 30, 2022 | 24.28% |
| March 31, 2022 | 24.28% |
| February 28, 2022 | 24.28% |
| January 31, 2022 | 24.28% |
| December 31, 2021 | 24.28% |
| November 30, 2021 | 29.60% |
| October 31, 2021 | 29.60% |
| September 30, 2021 | 32.59% |
| August 31, 2021 | 32.59% |
| July 31, 2021 | 32.59% |
| June 30, 2021 | 32.59% |
| May 31, 2021 | 32.59% |
| April 30, 2021 | 32.59% |
| March 31, 2021 | 32.59% |
| February 28, 2021 | 32.59% |
| January 31, 2021 | 32.59% |
| December 31, 2020 | 32.59% |
| November 30, 2020 | 32.59% |
| October 31, 2020 | 32.59% |
| September 30, 2020 | 32.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
24.28%
Minimum
Dec 2021
32.59%
Maximum
Nov 2019
28.24%
Average
25.65%
Median
Sep 2022
Max Drawdown (5Y) Benchmarks
| Adaptimmune Therapeutics PLC | 96.45% |
| Biodexa Pharmaceuticals PLC | 100.00% |
| Verona Pharma PLC | 89.71% |
| NuCana PLC | 99.28% |
| Autolus Therapeutics PLC | 96.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 2.220 |
| Beta (5Y) | 0.4637 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 25.61% |
| Historical Sharpe Ratio (5Y) | 0.3204 |
| Historical Sortino (5Y) | 0.5599 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.74% |